Newsroom

Media Contacts

 

USMedia@galderma.com

Zach Randles-Friedman, Head of U.S. Communications: +1 305 299 5700

Filter news by date

10 . 3 . 2022

Press Releases

Galderma and National Breast Cancer Foundation Announce Continued Partnership to Launch Campaign Elevating Skin Stories of Breast Cancer Survivors

9 . 27 . 2022

Press Releases  

Cetaphil® Celebrates 75 Years of Sensitive Skincare Leadership

6 . 30 . 2022

Press Releases  

Galderma and Children’s Skin Disease Foundation Celebrate Decade-Long Partnership

6 . 8 . 2022

Press Releases  

Galderma to present new findings from innovative product portfolio at the 2022 VCS Annual Symposium

6 . 2 . 2022

Press Releases  

Galderma Launches EPSOLAY® Cream, a Medical Advance to Treat Bumps and Blemishes of Rosacea

4 . 25 . 2022

 

Sol-Gel Technologies and Galderma Announce FDA Approval of EPSOLAY®

3 . 25 . 2022

Press Releases  

Galderma to highlight latest science and innovation across its product portfolio at the 2022 AAD Annual meeting

3 . 25 . 2022

Press Releases  

Galderma Launches TWYNEO® Cream, the First Ever Tretinoin and Benzoyl Peroxide Combination to Treat Facial Acne

3 . 10 . 2022

Press Releases  

Galderma Launches Breakthrough Innovation With ALASTIN Skincare® HA IMMERSE SERUM®

3 . 9 . 2022

Press Releases  

Cetaphil® Champions Sensitive Skin Initiative with an Entire Month of Science-Backed Educational Content

3 . 7 . 2022

Press Releases  

Differin® Joins Forces with Expert Digital Voices to Kickstart the Acne Conversation for Its Fifth-Annual Retinoid Education Week

2 . 14 . 2022

Press Releases  

Galderma Launches Alastin Skincare® ReFORM & RePAIR COMPLEX with TriHex Technology® Designed to Assist with Recovery from Aesthetic Surgical Body Procedures

1 . 5 . 2022

Press Releases  

Galderma successfully completes acquisition of ALASTIN Skincare®